Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Benkert

Showing results (121-130 of 135) with videos related to

Pageof 14
Sort By:
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 3, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple SclerosisJohanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2023
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsAlexandra Ramona Todea, Lester Melie-Garcia, Muhamed Barakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi StudyÖzgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Bioengineering (Basel, Switzerland)|August 29, 2024
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric CohortMartina Greselin, Po-Jui Lu, Lester Melie-Garcia, et al.
Neurology|January 2, 2024
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MSAlessandro Cagol, Pascal Benkert, Lester Melie-Garcia, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Journal of Neurology|May 16, 2026
Diagnostic and prognostic value of blood neurofilament light chain in ischemic stroke: an individual patient data meta-analysisLorenzo Barba, Michele Romoli, Pascal Benkert, et al.
Pageof 14

Showing results (121-130 of 135) with videos related to

Sort By:
Pageof 14
Journal of Neurology, Neurosurgery, and Psychiatry|November 8, 2023
Serum biomarker levels predict disability progression in patients with primary progressive multiple sclerosisNicolás Fissolo, Pascal Benkert, Jaume Sastre-Garriga, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 3, 2025
Aberrant Complement Activation Is Associated With Structural Brain Damage in Multiple SclerosisJohanna Oechtering, Sabine Anna Schaedelin, Kerstin Stein, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|December 6, 2024
Disease-modifying treatment and disability progression in subclasses of patients with primary progressive MS: results from the Big MS Data NetworkJohannes Lorscheider, Alessio Signori, Suvitha Subramaniam, et al.
Annals of Clinical and Translational Neurology|August 4, 2025
Serum Neurofilament Light Chain in Multiple Sclerosis: Superiority of Age- and BMI-Corrected Z Scores/Percentiles Over Absolute Cutoff Values for Prediction of Treatment ResponseMaximilian Einsiedler, Aleksandra Maleska Maceski, Sofia Sandgren, et al.
Journal of Magnetic Resonance Imaging : JMRI|January 28, 2023
A Multicenter Longitudinal MRI Study Assessing LeMan-PV Software Accuracy in the Detection of White Matter Lesions in Multiple Sclerosis PatientsAlexandra Ramona Todea, Lester Melie-Garcia, Muhamed Barakovic, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 29, 2025
Personalized treatment decision algorithms for the clinical application of serum neurofilament light chain in multiple sclerosis: A modified Delphi StudyÖzgür Yaldizli, Pascal Benkert, Lutz Achtnichts, et al.
Bioengineering (Basel, Switzerland)|August 29, 2024
Contrast-Enhancing Lesion Segmentation in Multiple Sclerosis: A Deep Learning Approach Validated in a Multicentric CohortMartina Greselin, Po-Jui Lu, Lester Melie-Garcia, et al.
Neurology|January 2, 2024
Association of Spinal Cord Atrophy and Brain Paramagnetic Rim Lesions With Progression Independent of Relapse Activity in People With MSAlessandro Cagol, Pascal Benkert, Lester Melie-Garcia, et al.
Brain : a Journal of Neurology|November 14, 2025
GFAP and NfL as predictors of disease progression and relapse activity in fingolimod-treated multiple sclerosisAleksandra Maleska Maceski, Pascal Benkert, Maximilian Einsiedler, et al.
Journal of Neurology|May 16, 2026
Diagnostic and prognostic value of blood neurofilament light chain in ischemic stroke: an individual patient data meta-analysisLorenzo Barba, Michele Romoli, Pascal Benkert, et al.
Pageof 14